Two major providers of NHS patient data to the pharmaceuticals industry are to merge in a £140m deal to give them greater scale in their battle with the American giant Palantir Technologies.
Two major providers of NHS patient data to the pharmaceuticals industry are to merge in a £140m deal to give them greater scale in their battle with the American giant Palantir Technologies.
